You are here: Industry Insights > Biologics

News List

AbbVie obtains licence for Turnstone Biologics’ oncolytic viral immunotherapies pharmaceufical-technology
October 13, 2017
Under the deal, AbbVie has obtained an exclusive option to licence up to three of Turnstone's latest oncolytic viral immunotherapies.
Pfizer goes to Court to allow competition for biologics and expand options for patients worldpharmanews
September 21, 2017
To ensure patients and providers have access to important, lower cost biosimilar medicines, Pfizer (NYSE:PFE) has filed suit in the U.S. District Court for the Eastern District of Pennsylvania against Johnson & Johnson (J&J).
Dragonfly Therapeutics Appoints Head of Biologics contractpharma
May 02, 2017
Grinberg brings track record of scientific accomplishments and creativity in protein-based drug development
Japanese pharma companies predict 17 per cent growth in 2017 financialexpress
April 26, 2017
CPhI research shows that the biologics and generics sector are driving growth over the next year
Global trade bodies issue guidance on biosimilar switching europeanpharmaceuticalreview
March 10, 2017
The European Federation of Pharmaceutical Industries and Associations (EFPIA), European Biopharmaceutical Enterprises (EBE) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) have issued joint guidance...
Sartorius Stedim Biotech launches two Single-use Sartocon Loop Assemblies with Integrated Polyethers pharmaasia
February 08, 2017
Assemblies save up to 60 percent on processing time and offer a safe approach to ultrafiltration of biologics and vaccines.
US FDA accepts Roche’s supplemental biologics licence application pharmaceutical-technology
January 11, 2017
The US Food and Drug Administration (FDA) has accepted Roche’s supplemental Biologics Licence Application (sBLA) and granted priority review for Tecentriq (atezolizumab) to treat people with locally advanced or metastatic urothelial carcinoma (mUC).

Previous page 1 2 3 4 5 6 7 8 9 Next page